General Rheumatology   

In what cases do you discontinue the medication?

I.e., what constitutes well-controlled cancer, IBD, nephrotic syndrome, etc. What other diseases do you put in this category (obesity, autoimmune dise...

Patient has no current evidence of underlying vasculitis or malignancy.

Do you frequently order liver biopsies for these patients?

Does your evaluation hinge on nonresolution with warming? How extensive is your workup?

Recent articles regarding the use of JAK-Inhibition in RA have suggested to avoid in patients with increased CV risk.  However, RA itself is cons...

Such as oral methylprednisolone, dexamethasone, prednisolone, etc.

Does treatment with B-cell depletion and/or negative anti-spike antibody status despite COVID mRNA vaccination influence your decision?

Do you attempt to taper fully or maintain at a low dose?

Specifically, how do you treat the delayed headache, not the headache that develops during the infusion where pre-hydration and slowing down the rate ...

How do you decide if it may be safe to continue immunotherapy?

Dr. Charles-Schoeman presented data at ACR 21 showing that, paradoxically, there is a U-shaped relationship between inflammation and LDL levels in pat...

Would you consider this for patients on B-cell depleting therapies or more broadly for other immunosuppressive agents?

Would you have a different opinion based on whether it is a new therapy or an existing and previously well-tolerated therapy for the patient?

Are there specific features that suggest drug-induced uveitis versus de novo uveitis?

There is some emerging evidence that there is an inflammatory component. 

To my understanding, sm/RNP should also be positive in this situation (and one would assume a positive ANA as well)